Vanguard Group
ARAV

Vanguard Group’s Aravive, Inc. Common Stock ARAV Stock Holding History

Vanguard Group’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,094,695
Closed -$135K – 4539
2023
Q4 		$135K Sell
1,094,695
-44,806
-4% -$6.13K ﹤0.01% 4267
2023
Q3 		$150K Sell
1,139,501
-443,972
-28% -$279K ﹤0.01% 4295
2023
Q2 		$2M Sell
1,583,473
-1,053,406
-40% -$1.71M ﹤0.01% 3660
2023
Q1 		$5.27M Buy
2,636,879
+2,212,724
+522% +$4.15M ﹤0.01% 3285
2022
Q4 		$560K Buy
424,155
+302
+0.1% +$386 ﹤0.01% 4069
2022
Q3 		$346K Sell
423,853
-33,367
-7% -$28.7K ﹤0.01% 4310
2022
Q2 		$452K Hold
457,220
– – ﹤0.01% 4315
2022
Q1 		$882K Sell
457,220
-63,023
-12% -$136K ﹤0.01% 4247
2021
Q4 		$1.14M Sell
520,243
-11,976
-2% -$39.8K ﹤0.01% 4233
2021
Q3 		$1.98M Buy
532,219
+10,897
+2% +$46.5K ﹤0.01% 4056
2021
Q2 		$3.12M Sell
521,322
-58,766
-10% -$311K ﹤0.01% 3823
2021
Q1 		$3.82M Buy
580,088
+7,031
+1% +$46.2K ﹤0.01% 3664
2020
Q4 		$3.23M Buy
573,057
+7,260
+1% +$39.8K ﹤0.01% 3532
2020
Q3 		$2.66M Buy
565,797
+15,047
+3% +$107K ﹤0.01% 3402
2020
Q2 		$6.41M Buy
550,750
+69,480
+14% +$824K ﹤0.01% 2984
2020
Q1 		$2.77M Buy
481,270
+77,323
+19% +$692K ﹤0.01% 3209
2019
Q4 		$5.52M Buy
403,947
+278,252
+221% +$2.46M ﹤0.01% 3137
2019
Q3 		$942K Sell
125,695
-33,339
-21% -$208K ﹤0.01% 3668
2019
Q2 		$955K Buy
159,034
+7,200
+5% +$44.9K ﹤0.01% 3690
2019
Q1 		$1.07M Buy
151,834
+23,751
+19% +$124K ﹤0.01% 3612
2018
Q4 		$451K Sell
128,083
-66,698
-34% -$384K ﹤0.01% 3755
2018
Q3 		$1.64M Buy
194,781
+1,057
+0.5% +$11.1K ﹤0.01% 3593
2018
Q2 		$2.35M Sell
193,724
-44,665
-19% -$460K ﹤0.01% 3451
2018
Q1 		$2.36M Buy
238,389
+47,054
+25% +$529K ﹤0.01% 3403
2017
Q4 		$2.52M Sell
191,335
-12,877
-6% -$166K ﹤0.01% 3354
2017
Q3 		$3M Buy
204,212
+17,312
+9% +$1.75M ﹤0.01% 3286
2017
Q2 		$19.6M Buy
186,900
+19,815
+12% +$2.13M ﹤0.01% 2467
2017
Q1 		$21.4M Buy
167,085
+16,930
+11% +$1.79M ﹤0.01% 2415
2016
Q4 		$13.4M Buy
150,155
+14,756
+11% +$1.12M ﹤0.01% 2607
2016
Q3 		$9.95M Buy
135,399
+20,491
+18% +$1.48M ﹤0.01% 2688
2016
Q2 		$7.63M Buy
114,908
+3,918
+4% +$223K ﹤0.01% 2778
2016
Q1 		$5.34M Buy
110,990
+8,923
+9% +$473K ﹤0.01% 2923
2015
Q4 		$7.59M Buy
102,067
+4,262
+4% +$286K ﹤0.01% 2785
2015
Q3 		$6.77M Buy
97,805
+19,308
+25% +$1.81M ﹤0.01% 2827
2015
Q2 		$7.17M Buy
78,497
+7,891
+11% +$799K ﹤0.01% 2840
2015
Q1 		$7.78M Buy
70,606
+40,060
+131% +$4.7M ﹤0.01% 2773
2014
Q4 		$4.11M Buy
30,546
+5,464
+22% +$639K ﹤0.01% 2997
2014
Q3 		$2.86M Buy
25,082
+417
+2% +$55.3K ﹤0.01% 3117
2014
Q2 		$4.15M Buy
+24,665
New +$4.26M ﹤0.01% 2935

Other funds holding ARAV

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Vanguard Group's ARAV Position: Q1 2024 in Review

Vanguard Group sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2024, closing a stake of 1,094,695 shares — an estimated $135K sold.

Vanguard Group first reported a position in ARAV in Q2 2014 and held it in 39 quarters. The position peaked at $21.4M in Q1 2017. 3 funds tracked by Wall St. Rank hold ARAV as of Q1 2024.

  • Vanguard Group reported no remaining Aravive, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Vanguard Group sold 1,094,695 Aravive, Inc. Common Stock shares in Q1 2024, an estimated $135K.
  • Vanguard Group first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 39 quarters.
  • Vanguard Group's Aravive, Inc. Common Stock position peaked at $21.4M in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2024.

Based on Vanguard Group's 13F filing for Q1 2024, filed 10 May 2024.